302 related articles for article (PubMed ID: 25151306)
21. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
[TBL] [Abstract][Full Text] [Related]
22. Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1/MuRF1 signaling pathway in vitro.
Chen BL; Ma YD; Meng RS; Xiong ZJ; Wang HN; Zeng JY; Liu C; Dong YG
Acta Pharmacol Sin; 2010 Jul; 31(7):798-804. PubMed ID: 20581852
[TBL] [Abstract][Full Text] [Related]
23. Cyclovirobuxinum D alleviates cardiac hypertrophy in hyperthyroid rats by preventing apoptosis of cardiac cells and inhibiting the p38 mitogen-activated protein kinase signaling pathway.
Wu JB; Zhou Y; Liang CL; Zhang XJ; Lai JM; Ye SF; Ouyang H; Lin J; Zhou JY
Chin J Integr Med; 2017 Oct; 23(10):770-778. PubMed ID: 27048408
[TBL] [Abstract][Full Text] [Related]
24. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II increases secreted frizzled-related protein 5 (sFRP5) expression through AT1 receptor/Rho/ROCK1/JNK signaling in cardiomyocytes.
Jin X; Guo B; Yan J; Yang R; Chang L; Wang Y; Miao C; Liu S; Zhang H; Li Y
Mol Cell Biochem; 2015 Oct; 408(1-2):215-22. PubMed ID: 26126628
[TBL] [Abstract][Full Text] [Related]
26. Secretoneurin suppresses cardiac hypertrophy through suppression of oxidant stress.
Chen HL; Liu Y; Jiang W; Wang XX; Yuan GL; Zhao YL; Yu C
Eur J Pharmacol; 2018 Mar; 822():13-24. PubMed ID: 29337195
[TBL] [Abstract][Full Text] [Related]
27. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
[TBL] [Abstract][Full Text] [Related]
28. AMP-activated protein kinase activates p38 mitogen-activated protein kinase by increasing recruitment of p38 MAPK to TAB1 in the ischemic heart.
Li J; Miller EJ; Ninomiya-Tsuji J; Russell RR; Young LH
Circ Res; 2005 Oct; 97(9):872-9. PubMed ID: 16179588
[TBL] [Abstract][Full Text] [Related]
29. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy.
Sopontammarak S; Aliharoob A; Ocampo C; Arcilla RA; Gupta MP; Gupta M
Cell Biochem Biophys; 2005; 43(1):61-76. PubMed ID: 16043884
[TBL] [Abstract][Full Text] [Related]
30. Exendin-4 attenuates cardiac hypertrophy via AMPK/mTOR signaling pathway activation.
Zhou Y; He X; Chen Y; Huang Y; Wu L; He J
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):394-9. PubMed ID: 26519882
[TBL] [Abstract][Full Text] [Related]
31. RGS2 is upregulated by and attenuates the hypertrophic effect of alpha1-adrenergic activation in cultured ventricular myocytes.
Zou MX; Roy AA; Zhao Q; Kirshenbaum LA; Karmazyn M; Chidiac P
Cell Signal; 2006 Oct; 18(10):1655-63. PubMed ID: 16517124
[TBL] [Abstract][Full Text] [Related]
32. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG
J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062
[TBL] [Abstract][Full Text] [Related]
33. Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts.
Hayashida W; Kihara Y; Yasaka A; Inagaki K; Iwanaga Y; Sasayama S
J Mol Cell Cardiol; 2001 Apr; 33(4):733-44. PubMed ID: 11273726
[TBL] [Abstract][Full Text] [Related]
34. Sestrin 2 attenuates neonatal rat cardiomyocyte hypertrophy induced by phenylephrine via inhibiting ERK1/2.
Dong B; Xue R; Sun Y; Dong Y; Liu C
Mol Cell Biochem; 2017 Sep; 433(1-2):113-123. PubMed ID: 28497371
[TBL] [Abstract][Full Text] [Related]
35. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
[TBL] [Abstract][Full Text] [Related]
36. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.
Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J
Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704
[TBL] [Abstract][Full Text] [Related]
37. Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production.
Bao W; Behm DJ; Nerurkar SS; Ao Z; Bentley R; Mirabile RC; Johns DG; Woods TN; Doe CP; Coatney RW; Ohlstein JF; Douglas SA; Willette RN; Yue TL
J Cardiovasc Pharmacol; 2007 Jun; 49(6):362-8. PubMed ID: 17577100
[TBL] [Abstract][Full Text] [Related]
38. Indoxyl sulfate induces oxidative stress and hypertrophy in cardiomyocytes by inhibiting the AMPK/UCP2 signaling pathway.
Yang K; Xu X; Nie L; Xiao T; Guan X; He T; Yu Y; Liu L; Huang Y; Zhang J; Zhao J
Toxicol Lett; 2015 Apr; 234(2):110-9. PubMed ID: 25703824
[TBL] [Abstract][Full Text] [Related]
39. Heme oxygenase-1 gene transfer inhibits angiotensin II-mediated rat cardiac myocyte apoptosis but not hypertrophy.
Foo RS; Siow RC; Brown MJ; Bennett MR
J Cell Physiol; 2006 Oct; 209(1):1-7. PubMed ID: 16826603
[TBL] [Abstract][Full Text] [Related]
40. Suppression of calcium‑sensing receptor ameliorates cardiac hypertrophy through inhibition of autophagy.
Liu L; Wang C; Lin Y; Xi Y; Li H; Shi S; Li H; Zhang W; Zhao Y; Tian Y; Xu C; Wang L
Mol Med Rep; 2016 Jul; 14(1):111-20. PubMed ID: 27176663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]